Astute Medical Launches European Sales of Nephrocheck AKI Risk Assessment Test
October 19, 2012
Astute Medical Launches European Sales of Nephrocheck AKI Risk Assessment Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Multi-Site Validation Study Published Supporting Astute Medical's NephroCheck AKI Test
February 8, 2013 / ProteoMonitor - Astute Medical Completes $40M Series C Funding Round
June 8, 2012 / ProteoMonitor - Astute Medical Raises $13M for Protein Biomarker Dx Development
March 11, 2011 / ProteoMonitor - Columbia Team IDs Two Protein Markers to Improve Prediction of Acute Kidney Injury, Adverse Effects
January 13, 2012 / ProteoMonitor - Yale-Led Group Links Protein Markers to Kidney Injury in Cardiac Surgery Patients
August 26, 2011 / ProteoMonitor